Citadel Advisors
BIND

Citadel Advisors’s BIND THERAPEUTICS INC BIND Stock Holding History

Citadel Advisors’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32,620
Closed -$13K – 8309
2016
Q2 		$13K Buy
+32,620
New +$26.8K ﹤0.01% 6711

Citadel Advisors's BIND Position: Q3 2016 in Review

Citadel Advisors sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 32,620 shares — an estimated $13K sold.

Citadel Advisors first reported a position in BIND in Q2 2016 and held it in 1 quarter. The position peaked at $13K in Q2 2016. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

  • Citadel Advisors reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Citadel Advisors sold 32,620 BIND THERAPEUTICS INC shares in Q3 2016, an estimated $13K.
  • Citadel Advisors first reported a position in BIND THERAPEUTICS INC in Q2 2016 and held it in 1 quarter.
  • Citadel Advisors's BIND THERAPEUTICS INC position peaked at $13K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.